MARIYA KIRIK: Open Payments
NPI 1437802659 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 45 payments from 15 companies in 2025. Trend: 2023 $617 · 2024 $1,335 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $197 |
| E.R. Squibb & Sons, L.L.C. | 9 | $142 |
| PFIZER INC. | 4 | $79 |
| Amgen Inc. | 3 | $71 |
| ABIOMED | 2 | $69 |
| Novo Nordisk Inc | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $59 |
| SCPHARMACEUTICALS INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $42 |
Products named: LEQVIO, ELIQUIS, Repatha, Wegovy, Kerendia, FUROSCIX, CAMZYOS, VYNDAQEL.
Industry payments across MA — which companies pay providers there.
